Pop, Alexander
Halegoua-DeMarzio, Dina
Barnhart, Huiman
Kleiner, David
Avigan, Mark
Gu, Jiezhun
Chalasani, Naga
Ahmad, Jawad
Fontana, Robert J.
Lee, William
Barritt, A. Sidney
Durazo, Francisco
Hayashi, Paul H.
Navarro, Victor J. http://orcid.org/0000-0002-8428-8528
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (U01DK083027)
Article History
Received: 18 September 2023
Accepted: 14 December 2023
First Online: 28 February 2024
Declarations
:
: Pop, Alexander- No conflicts with the content of this paper. Halegoua-DeMarzio, Dina—No conflicts with the content of this paper. Barnhart, Huiman—No conflicts with the content of this paper. Kleiner, David—No conflicts with the content of this paper. Avigan, Mark I – No conflicts with the content of the paper. Chalasani, Naga – No conflicts with the content of this paper. For full disclosure, Dr Chalasani has paid consulting agreements with Madrigal, Zydus, Altimmune, Foresite, GSK and Merck. He has research support from DSM and Exact Sciences. Ahmad, Jawad. – No conflicts with the content of this paper. Fontana, Robert J.—No conflicts with the content of this paper. Gu, Jiezhun.—No conflicts with the content of this paper. Lee, William – Receives research funding from Intercept, Aurora, Gilead, NovoNordisk, Alexion, Camurus, Lipocine and Eiger; consultant for Glaxo Smith Klein, Veristat, SeaGen, Cortexyme, Seal Rock, and Forma. Barritt, A. Sidney—No conflicts with the content of this paper. Durazo, Francisco—No conflicts with the content of this paper. Hayashi, Paul H -No conflicts with the content of this paper. Navarro, Victor J – No conflicts with the content of this paper.